Journal: bioRxiv

Article Title: Epoxyeicosatrienoic acids and sEH inhibition prevent cardiac dysfunction in CVB3-induced myocarditis by positively regulating type I interferon signaling

doi: 10.1101/2023.02.03.527086

Figure Lengend Snippet: ( A ) Phosphorylation of IRF3 (on Ser396) in uninfected (CON) or CVB3-infected AC16 cells treated with 11,12-EET, 14,15-EET or TPPU (n=4). ( B ) Dimerization of IRF3 in uninfected (CON) or CVB3-infected AC16 cells treated with 11,12-EET, 14,15-EET or TPPU (n=4). ( C ) Nuclear translocation of IRF3 in uninfected (CON) or CVB3-infected AC16 cells treated with 11,12-EET, 14,15-EET or TPPU (n=4). GAPDH and LaminA/C were used as cytoplasm and nuclear protein loading controls. ( D ) Immunofluorescence images showing the impact of 14,15-EET and TPPU on the subcellular localization of IRF3 in uninfected (CON) or CVB3-infected AC16 cells; bars =50 μm. ( E ) Scheme showing the two main RNA sensor-induced IRF3 activation pathways. ( F-G ) AC16 cells that were uninfected (CON) or infected with CVB3 were treated with 11,12-EET, 14,15-EET or TPPU (n=3). Shown are changes in IRF3 phosphorylation following the siRNA-mediated down regulation of MDA5 (F), or TLR3 (G). ( H ) Activity of a IFNβ-luciferase reporter construct in HEK293 cells expressing either a control vector (vector), pcMDA5, pcMAVS, pcTBK1 , or pcIRF3-5D and treated with solvent (CON) or 14,15-EET (1 μM) for 24 hours. ( I ) Impact of the siRNA-mediated downregulation of TBK1 on the phosphorylation of IRF3 (on Ser396) in uninfected (CON) or CVB3-infected AC16 cells treated with 11,12-EET, 14,15-EET or TPPU (n=3). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

Article Snippet: After 48 hours, transfected HEK293 cells were harvested in immunoprecipitation (IP) buffer containing 20 mM Tris (pH7.5), 150 mM NaCl, 1% Triton X-100 with freshly added PMSF, protease inhibitors and phosphatase inhibitors (Boster Biological Tech, Wuhan, China).

Techniques: Phospho-proteomics, Infection, Translocation Assay, Immunofluorescence, Activation Assay, Activity Assay, Luciferase, Construct, Expressing, Control, Plasmid Preparation, Solvent

Journal: bioRxiv

Article Title: Epoxyeicosatrienoic acids and sEH inhibition prevent cardiac dysfunction in CVB3-induced myocarditis by positively regulating type I interferon signaling

doi: 10.1101/2023.02.03.527086

Figure Lengend Snippet: ( A ) Impact of the siRNA-mediated downregulationof GSK3β on the phosphorylation of IRF3 (on Ser396) in uninfected (CON) or CVB3-infected AC16 cells treated with 11,12-EET, 14,15-EET or TPPU (n=4). ( B ) Impact of the EET antagonist; EEZE (1 μM) on the phosphorylation of GSK3β in AC16 cells treated with 11,12-EET, 14,15-EET or TPPU (n=4). ( C ) Co-immunoprecipitation of TBK1 with a GSK3β-Flag fusion protein from HEK293 cells treated with 14,15-EET (1 μM) or TPPU (10 μM) in the absence or presence of EEZE (n=3). ( D ) Impact of the wild-type GSK3β and the Y216F and Y216D GSK3β mutants on the phosphorylation of TBK1 in uninfected and CVB3-infected HEK293 cells (n=3). ( E-F ) Impact of GSK3β mutation alone and in combination with 14,15-EET on the phosphorylation of TBK1 in uninfected and CVB3-infected HEK293 cells (n=3-4). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

Article Snippet: After 48 hours, transfected HEK293 cells were harvested in immunoprecipitation (IP) buffer containing 20 mM Tris (pH7.5), 150 mM NaCl, 1% Triton X-100 with freshly added PMSF, protease inhibitors and phosphatase inhibitors (Boster Biological Tech, Wuhan, China).

Techniques: Phospho-proteomics, Infection, Immunoprecipitation, Mutagenesis

Journal: The Journal of Biological Chemistry

Article Title: Discovery of small molecules and a druggable groove that regulate DNA binding and release of the AP-1 transcription factor ΔFOSB

doi: 10.1016/j.jbc.2025.111080

Figure Lengend Snippet: Cellular activity of JPC0661 . A , cell viability of JPC0661 comm and HTS10307 assessed in the range of 0 to 20 μM after 24 h ( top ) and 72 h ( bottom ) in neural progenitor cells (NPCs) using the CellTiter-Glo viability assay. Cell viability measures are normalized to the negative control containing no compound but 0.6% DMSO. Dotted lines indicate 100% cell viability. The mean of n replicates is shown for 24 h (n = 3) and 72 h (n = 2) with error bars indicating the SEM. B , stability of JPC0661 comm and HTS10307 in mouse liver microsomes. C and D , effects of JPC0661 comm (0–100 μM; ( C ) and JPC0661 (0–100 μM; ( D ) on AP-1-driven luciferase activity in AP-1-luc HEK293 cells. The dose-dependent activation of the AP-1-driven luciferase reporter was measured based on changes in the luciferase signal and expressed as relative fluorescence units (RFUs). Each compound was tested twice (n = 4 wells per experiment; total n = 6–8 wells for JPC0661 comm and n = 7–8 wells for JPC0661 per concentration), with results normalized to the luciferase signals of blank wells from corresponding experiments (n = 8 wells). Nonlinear regression using a three-parameter model was applied to fit the luciferase signal and calculate IC 50 values, which are reported with a 95% confidence interval (CI), and data points are presented as the mean ± SEM. E , effect of serially diluted JPC0661 (0.003–100 μM) on the viability of AP-1-luc HEK293 cells using the Celltiter-Glo viability assay (2 h). Cell viability was normalized to the DMSO control, which contained 0.5% DMSO but no compound (n = 7 wells). Data points are presented as the mean ± SEM, with a total n = 10 to 12 wells per concentration. F , effect of JPC0661 (at doses 12.5, 25, and 50 μM) on the viability of Neuro 2A cells (72 h) using the Celltiter-Glo viability assay to assess potential toxicity in mouse neuronal cells. Cell viability was normalized to the DMSO control, which contained 0.5% DMSO but no compound (n = 8 wells). Data points are presented as the mean ± SEM, with a total n = 12 wells per concentration. AP-1, activator protein 1; DMSO, dimethyl sulfoxide.

Article Snippet: The AP-1-luciferase reporter HEK293 cell line was obtained from BPS Bioscience and maintained in growth medium 1B (BPS Bioscience) supplemented with 10% fetal bovine serum (FBS; Invitrogen) and 1% penicillin–streptomycin (Hyclone) under standard incubation conditions of 37 °C with 5% CO 2 .

Techniques: Activity Assay, Viability Assay, Negative Control, Luciferase, Activation Assay, Fluorescence, Concentration Assay, Control

Journal: The Journal of Biological Chemistry

Article Title: Discovery of small molecules and a druggable groove that regulate DNA binding and release of the AP-1 transcription factor ΔFOSB

doi: 10.1016/j.jbc.2025.111080

Figure Lengend Snippet: Validation of JPC0661 as an inhibitor of ΔFOSB . A , a panel of JPC0661 analogs was designed to probe the role of the sulfonic acid group and the amino-pyrazolone group. B , the table summarizing the JPC0661 analogs tested in AP-1-reporter assays using AP-1-luc HEK293 cells, yielding cell-based IC 50 values and FP-DRC assays. Lower IC 50 values are marked with more plus signs (+) and indicate higher activity. The plots from the FP-DRC and cell-based DRC assays for these compounds are shown in . C , ΔFOSB–JUND bZIP incubated with compounds (0.5 mM) with 100 μM diamide (“ ox ,” oxidized) or without diamide (“ red ,” reduced) and assessed by SDS-PAGE (with or without reducing agent in the loading buffer). D , ΔFOSB–JUND bZIP protein incubated with compounds (0.5 mM) with no diamide (“ red ”) or protein alone (no compound) incubated with diamide (“ ox ”) as a control and then assessed by SDS-PAGE (with or without reducing agent in the loading buffer). In ( C ) and ( D ), “cntrl” denotes the ΔFOSB–JUND bZIP protein in the absence of compound. AP-1, activator protein 1; bZIP, basic leucine zipper; FP-DRC, fluorescence polarization–dose–response curve; HEK293, human embryonic kidney 293 cell line.

Article Snippet: The AP-1-luciferase reporter HEK293 cell line was obtained from BPS Bioscience and maintained in growth medium 1B (BPS Bioscience) supplemented with 10% fetal bovine serum (FBS; Invitrogen) and 1% penicillin–streptomycin (Hyclone) under standard incubation conditions of 37 °C with 5% CO 2 .

Techniques: Biomarker Discovery, Activity Assay, Incubation, SDS Page, Control, Fluorescence

Journal: bioRxiv

Article Title: Lipid moieties of sonic hedgehog are important for interaction with its inhibitor, WIF1

doi: 10.64898/2026.02.23.707386

Figure Lengend Snippet: Comparison of the signaling activities of rhShh_8908-SH, rhShh_1314-SH and rhShh_1845-SH in the Gli Reporter-NIH3T3 cell line reporter assay. Panel A: rhShh_8908-SH expressed in HEK293 cells was applied at 0–600 nM. EC 50 = 34.22 ± 2.25 nM. Panel B: rhShh_1314-SH expressed in E. coli was applied at 0–2400 nM. EC 50 = 64.81 ± 1.29 nM. Panel C: rhShh_1845-SH expressed in E. coli was applied at 0–2400 nM. EC 50 = 86.09 ± 1.11 nM. In all assays, Gli Reporter-NIH3T3 cells were grown to confluency, the culture medium was removed, and cells were treated with 50 μL aliquots of the indicated Shh concentrations. Data represent one experiment performed in triplicate and are expressed as fold induction relative to luminescence at 0 nM Shh.

Article Snippet: The ONE-StepTM Luciferase Assay System and the Gli Reporter-NIH3T3 cell line were purchased from BPS Bioscience (Inc., San Diego, CA, USA).

Techniques: Comparison, Reporter Assay

Journal: bioRxiv

Article Title: Lipid moieties of sonic hedgehog are important for interaction with its inhibitor, WIF1

doi: 10.64898/2026.02.23.707386

Figure Lengend Snippet: Inhibition of the signaling activities of rhShh_8908-SH, rhShh_1314-SH and rhShh_1845-SH proteins by human WIF1 protein in the Gli Reporter-NIH3T3 cell line reporter assay. Panel A: Inhibition of human rhShh_8908-SH expressed in HEK293 cells (15 nM) by rhWIF1 (0–1000 nM); EC 50 = 3.78 ± 0.13 nM. Panel B: Inhibition of rhShh_1314-SH expressed in E. coli (15 nM) by rhWIF1 (0–1200 nM); EC 50 = 6.83 ± 0.89 nM. Panel C: Inhibition of rhShh_1845-SH expressed in E. coli (15 nM) by rhWIF1 (0–1200 nM); EC 50 = 15.71 ± 1.75 nM. In all assays, Gli Reporter-NIH3T3 cells were grown to confluency, culture medium was removed, and cells were treated with 50 μL aliquots of rhShh preincubated for 5 min with rhWIF1. Data represent representative experiments performed in triplicate (B, C) or quadruplicate (A) and are expressed as fraction of luminescence relative to 0 nM rhWIF1.

Article Snippet: The ONE-StepTM Luciferase Assay System and the Gli Reporter-NIH3T3 cell line were purchased from BPS Bioscience (Inc., San Diego, CA, USA).

Techniques: Inhibition, Reporter Assay